Chemoinformaics analysis of (1R)-2-methyl-5-propan-2-ylbicyclo[3.1.0]hex-2-ene
Molecular Weight | 136.238 | nRot | 1 |
Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
Exact Molecular Weight | 136.125 | nRing | 2 |
Solubility: LogS | -3.747 | nHRing | 0 |
Solubility: LogP | 3.907 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.3687 |
nHD | 0 | BPOL | 16.0513 |
QED | 0.486 |
Synth | 4.391 |
Natural Product Likeliness | 3.138 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.272 |
MDCK | 0.0000253 |
BBB | 0.403 |
PPB | 0.903263 |
VDSS | 2.251 |
FU | 0.112216 |
CYP1A2-inh | 0.763 |
CYP1A2-sub | 0.374 |
CYP2c19-inh | 0.248 |
CYP2c19-sub | 0.898 |
CYP2c9-inh | 0.135 |
CYP2c9-sub | 0.195 |
CYP2d6-inh | 0.08 |
CYP2d6-sub | 0.365 |
CYP3a4-inh | 0.284 |
CYP3a4-sub | 0.295 |
CL | 17.105 |
T12 | 0.215 |
hERG | 0.027 |
Ames | 0.016 |
ROA | 0.148 |
SkinSen | 0.191 |
Carcinogencity | 0.725 |
EI | 0.985 |
Respiratory | 0.481 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.906851 |